Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: a multicentre experience from tertiary referral hospitals.
Avallone, G; Maronese, C A; Conforti, C; Fava, P; Gargiulo, L; Marzano, A V; Massone, C; Mastorino, L; Paradisi, A; Pileri, A; Quaglino, P; Rizzo, N; Ribero, S; Roccuzzo, G; Tavoletti, G; Vignoli, C A; Zalaudek, I; Berti, E; Alberti-Violetti, S.
J Eur Acad Dermatol Venereol ; 2022 Dec 05.
Article in English | MEDLINE | ID: covidwho-2250567
2.
A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine.
Filippi, F; Baraldi, C; Zinzani, P L; Casadei, B; Pileri, A.
J Eur Acad Dermatol Venereol ; 36(10): e747-e749, 2022 10.
Article in English | MEDLINE | ID: covidwho-1986023

Subject(s)
COVID-19 Vaccines , COVID-19 , Pityriasis Lichenoides , Aged , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Humans , Male
3.
Estimating the incidence of COVID-19 skin manifestations on the general population in a territorial setting.
Zengarini, C; Guglielmo, A; Giovani, M; Preci, C; Dika, E; Piraccini, B M; Pileri, A.
J Eur Acad Dermatol Venereol ; 36(6): e415-e417, 2022 06.
Article in English | MEDLINE | ID: covidwho-1649190

Subject(s)
COVID-19 , COVID-19/epidemiology , Humans , Incidence , SARS-CoV-2
4.
Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitis.
Zengarini, C; Pileri, A; Salamone, F P; Piraccini, B M; Vitale, G; La Placa, M.
J Eur Acad Dermatol Venereol ; 36(3): e179-e180, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1528393

Subject(s)
COVID-19 , Liver Cirrhosis, Biliary , Lupus Erythematosus, Cutaneous , Lupus Erythematosus, Systemic , COVID-19 Vaccines , Humans , SARS-CoV-2
5.
In-depth, single-centre, analysis of changes in emergency service access after the spread of COVID-19 across Italy.
Ferrari, T; Zengarini, C; Bardazzi, F; Pileri, A.
Clin Exp Dermatol ; 46(8): 1588-1589, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1255369

Subject(s)
COVID-19/epidemiology , Disease Outbreaks/statistics & numerical data , Emergency Medical Services/statistics & numerical data , Health Services Accessibility/statistics & numerical data , COVID-19/diagnosis , COVID-19/virology , Data Interpretation, Statistical , Dermatology/standards , Emergency Medical Services/trends , Health Services Accessibility/trends , Humans , Italy/epidemiology , Prospective Studies , SARS-CoV-2/genetics
6.
Chilblain lesions after COVID-19 mRNA vaccine.
Pileri, A; Guglielmo, A; Raone, B; Patrizi, A.
Br J Dermatol ; 185(1): e3, 2021 07.
Article in English | MEDLINE | ID: covidwho-1201188

Subject(s)
COVID-19 , Chilblains , COVID-19 Vaccines , Chilblains/etiology , Humans , RNA, Messenger , SARS-CoV-2
7.
Changes in emergency service access after spread of COVID-19 across Italy.
Tartari, F; Guglielmo, A; Fuligni, F; Pileri, A.
J Eur Acad Dermatol Venereol ; 34(8): e350-e351, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-125457

Subject(s)
Betacoronavirus/isolation & purification , Coronavirus Infections/epidemiology , Emergency Service, Hospital/organization & administration , Health Services Accessibility , Pneumonia, Viral/epidemiology , COVID-19 , Coronavirus Infections/transmission , Coronavirus Infections/virology , Female , Humans , Italy/epidemiology , Male , Pandemics , Pneumonia, Viral/transmission , Pneumonia, Viral/virology , SARS-CoV-2
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL